J
Jeffrey L. Johnson
Researcher at Duke University
Publications - 165
Citations - 10481
Jeffrey L. Johnson is an academic researcher from Duke University. The author has contributed to research in topics: Cancer & Mantle cell lymphoma. The author has an hindex of 55, co-authored 157 publications receiving 9759 citations. Previous affiliations of Jeffrey L. Johnson include Durham University.
Papers
More filters
Journal ArticleDOI
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.
Christopher C. Silliman,Norbert F. Voelkel,Jenny D. Allard,David J. Elzi,Rubin M. Tuder,Jeffrey L. Johnson,D R Ambruso +6 more
TL;DR: Both plasma and lipids from stored blood produced pulmonary damage in a model of acute lung injury, and both caused ALI without vasoconstriction, except at the highest dose employed.
Journal ArticleDOI
Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial
David B. Duggan,Gina R. Petroni,Jeffrey L. Johnson,John H. Glick,Richard I. Fisher,Joseph M. Connors,George P. Canellos,Bruce A. Peterson +7 more
TL;DR: ABVD and the MOPP/ABV hybrid are effective therapies for Hodgkin's disease and ABVD should be considered the standard regimen for treatment of advanced Hodgkin’s disease.
Journal ArticleDOI
Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?
Jeffry L. Kashuk,Ernest E. Moore,Jeffrey L. Johnson,James B. Haenel,Michael L. Wilson,John B. Moore,C. Clay Cothren,Walter L. Biffl,Anirban Banerjee,Angela Sauaia +9 more
TL;DR: The findings indicate that the relationship between coagulopathy and mortality is more complex, and further clinical investigation is necessary before recommending routine 1:1 FFP:RBC in the exsanguinating trauma patient.
Journal ArticleDOI
Abdominal perfusion pressure: a superior parameter in the assessment of intra-abdominal hypertension.
TL;DR: Abdominal perfusion pressure appears to be a clinically useful resuscitation endpoint and predictor of patient survival during treatment for intra-abdominal hypertension and abdominal compartment syndrome.
Journal ArticleDOI
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
James L. Rubenstein,Eric D. Hsi,Jeffrey L. Johnson,Sin-Ho Jung,Megan O. Nakashima,Barbara Grant,Bruce D. Cheson,Lawrence D. Kaplan +7 more
TL;DR: It is demonstrated for the first time to the authors' knowledge that dose-intensive consolidation for PCNSL is feasible in the multicenter setting and yields rates of PFS and OS at least comparable to those of regimens involving WBRT.